Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Xeroderma Pigmentosum Clinical Trials
Xeroderma Pigmentosum clinical trials are recruiting across 58 cities. Here are the cities with the most active studies:
Xeroderma Pigmentosum Trial Phases
43 research organizations are sponsoring xeroderma pigmentosum trials.
About Xeroderma Pigmentosum
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
Clinical trials are advancing new treatments for xeroderma pigmentosum. Currently, 52 studies are recruiting a combined 49,604 participants across the United States. Research is being conducted by 43 organizations including NYU Langone Health, Guerbet, University of Texas at Austin and 40 others.
2026 Xeroderma Pigmentosum Research Landscape
As of July 2026, the xeroderma pigmentosum clinical trial landscape includes 52 actively recruiting studies across 58 cities in the United States. These studies are collectively seeking 49,604 participants, with an average enrollment target of 954 per study.
The research spans multiple phases of development: 26 studies are in NA, 8 studies are in PHASE2, 6 studies are in PHASE1, 2 studies are in PHASE4, 2 studies are in EARLY_PHASE1. Early-phase studies suggest new therapeutic approaches are being explored for xeroderma pigmentosum.
Research is being led by 43 different organizations, including NYU Langone Health, Guerbet, University of Texas at Austin, Memorial Sloan Kettering Cancer Center, Loma Linda University, and 38 others. The large number of sponsors reflects significant research interest and investment in xeroderma pigmentosum treatment advancement.
Geographically, xeroderma pigmentosum trials are most concentrated in New York, New York (6 trials); Boston, Massachusetts (3 trials); Chapel Hill, North Carolina (3 trials); Iowa City, Iowa (3 trials); Columbus, Ohio (3 trials) and 7 other cities.
Featured Xeroderma Pigmentosum Studies
Highlighted recruiting studies for xeroderma pigmentosum, selected by enrollment size and research scope.
NYU/Bellevue WTC Health Impacts Research Registry
The American Red Cross has funded a multidisciplinary, comprehensive evaluation and treatment program for target individuals with suspected World Trade Center (WTC)-related health problems. The populations served consist predominantly of a) local residents who were impacted by the disperion of the WTC dusts and fumes, b) individuals involved in cleaning and debris removal of local commercial space...
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the organs and tissue of the human body during x-ray, CT-scan or MRI investigations, doctors are using contrast media (a kind of dye) which can be given to patients by injection into a blood vessel or by mout...
Sudden Unexplained Death in Childhood (SUDC) Registry
The purpose is to increase the understanding of the characteristics, circumstances, medical histories and pathologies of children from ages 11 months through 18 years who have died suddenly and unexpectedly, and in some instances, without explanation. The SUDC Registry and Research Collaborative will analyze cases of sudden unexpected deaths in these children to understand risk factors and causes,...
Frequently Asked Questions About Xeroderma Pigmentosum Clinical Trials
Are there xeroderma pigmentosum clinical trials near me?
Yes, there are 52 xeroderma pigmentosum clinical trials currently recruiting across 58+ cities in the United States, including New York, New York; Boston, Massachusetts; Chapel Hill, North Carolina. Browse the studies above to find one at a location convenient for you.
How do I join a xeroderma pigmentosum clinical trial?
To join a xeroderma pigmentosum clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are xeroderma pigmentosum clinical trials free?
Yes, participation in xeroderma pigmentosum clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of xeroderma pigmentosum treatments are being studied?
Current xeroderma pigmentosum clinical trials are testing a range of approaches across NA (26 studies), PHASE2 (8 studies), PHASE1 (6 studies), PHASE4 (2 studies), EARLY_PHASE1 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 43 research organizations.
Is it safe to participate in xeroderma pigmentosum clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov